Director / Senior Director, Regulatory CMC (Biologics)
Oruka Therapeutics
| Company | Oruka Therapeutics |
| Category | Legal & Compliance |
| Location | Waltham |
| Remote | On-site (inferred) |
| Employment | Not stated |
| Level | Director |
| Salary | Not stated by the employer |
| Posted | 10 Apr 2026 |
| Last verified | 12 Aug 2026 |
| Source | Employer ATS (greenhouse) |
Description
About Us:
Oruka Therapeutics (Nasdaq: ORKA) is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin diseases like plaque psoriasis the greatest possible freedom from their condition by achieving high rates of complete disease clearance with dosing as infrequently as once or twice per year. Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies that were engineered by Paragon Therapeutics and target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. For more information, visit www.orukatx.com
As we build our core team, we're seeking top talent in different functional areas who are not just looking for a job, but an opportunity to be part of something bigger. Someone who is passionate about making a difference and eager to contribute to establishing an engaged, inclusive, and positive company culture. Job Title: Director / Senior Director, Regulatory CMC (Biologics)
Location: Hybrid – Waltham, MA Candidates will be required to be in-office 3 days/week.
Role Overview:
We are seeking an experienced and motivated regulatory CMC leader to shape strategy and execution across early-to-late-stage biologics programs. In this role, you will own the development of high-quality regulatory CMC submissions and guide cross-functional teams on phase-appropriate global regulatory expectations. You are an ideal candidate if you bring deep expertise in biologics development and manufacturing, including strong experience with drug substance and drug product CMC submissions. You will have the opportunity to influence program strategy, foster collaboration across CMC, QA, RA, Supply Chain, and external partners, and drive key decisions that support multiple programs in our rapidly growing biologics pipeline. This is a highly visible role where you will be responsible for submissions that are aligned with FDA, EMA, ICH, and WHO guidelines while supporting corporate and program level objectives.
Key Responsibilities:
Own and drive global regulatory CMC strategy for drug substance and drug product across all stages (IND through BLA)
Lead development of high-quality CMC dossiers, timelines, and submission strategies for global filings
Serve as the CMC regulatory SME on program teams, influencing cross-functional decisions and overall development strategy
Collaborate with CMC, Supply chain, QA and RA functions to support maintenance of product compliance, shelf life, and change control procedures
Lead cross-functional coordination to plan and deliver timely, high-quality responses to CMC regulatory information requests
Ensure all submissions meet phase-appropriate expectations and align with FDA, HC, EMA, ICH, and WHO guidelines
Anticipate regulatory risks and proactively develop mitigation strategies to keep programs on track
Collaborate effectively with internal teams and external partners including CDMOs to generate high quality source documents
Guide late-stage development planning, including process characterization, PPQ, and readiness for commercial filings
Bring a clear, proactive, solution-oriented mindset with the attitude to manage competing priorities
Thrive in a fast-paced biotech environment where agility and accountability matter
Contribute to a culture of collaboration, transparency, and continuous improvement
Qualifications:
MS or PhD in life sciences with 10+ years of experience in a biologics focused CMC role and a minimum of 5+ years of direct regulatory CMC experience
Strong command of cGMPs, biologics development (manufacturing, release, stability) and associated global regulatory expectations. Experience with drug device combinations (e.g., prefilled syringes, auto injectors